The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124467318 12446731 8 F 20160922 20160608 20160928 EXP US-PFIZER INC-2016246708 PFIZER 75.00 YR M Y 78.50000 KG 20160928 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124467318 12446731 1 PS SUTENT SUNITINIB MALATE 1 Oral 50 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) Y 21938 50 MG CAPSULE, HARD
124467318 12446731 2 C ZOLOFT SERTRALINE HYDROCHLORIDE 1 20 MG, DAILY 0 20 MG
124467318 12446731 3 C VITAMIN B COMPLEX CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX 1 Oral UNK, DAILY 0 TABLET
124467318 12446731 4 C DHEA PRASTERONE 1 Oral UNK 0 TABLET
124467318 12446731 5 C FINASTERIDE. FINASTERIDE 1 Oral 5 MG, DAILY 0 5 MG TABLET
124467318 12446731 6 C LABETALOL HCL LABETALOL HYDROCHLORIDE 1 Oral 200 MG, 2X/DAY 0 200 MG TABLET BID
124467318 12446731 7 C LOSARTAN POTASSIUM. LOSARTAN POTASSIUM 1 Oral 50 MG, DAILY 0 50 MG TABLET
124467318 12446731 8 C VITAMIN D3 CHOLECALCIFEROL 1 Oral UNK, DAILY 0 TABLET
124467318 12446731 9 C OXYCODONE HYDROCHLORIDE. OXYCODONE HYDROCHLORIDE 1 UNK 0 TABLET
124467318 12446731 10 C VELTASSA PATIROMER 1 Oral UNK 0
124467318 12446731 11 C COZAAR LOSARTAN POTASSIUM 1 UNK 0
124467318 12446731 12 C LABETALOL LABETALOLLABETALOL HYDROCHLORIDE 1 UNK 0
124467318 12446731 13 C PROSCAR FINASTERIDE 1 Oral 5 MG, DAILY 0 5 MG
124467318 12446731 14 C OXYCODONE OXYCODONE 1 UNK 0
124467318 12446731 15 C VITAMIN D CHOLECALCIFEROL 1 UNK 0
124467318 12446731 16 C COQ10 UBIDECARENONE 1 UNK 0
124467318 12446731 17 C XARELTO RIVAROXABAN 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124467318 12446731 1 Renal cancer stage IV

Outcome of event

Event ID CASEID OUTC COD
124467318 12446731 OT
124467318 12446731 HO
124467318 12446731 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
124467318 12446731 Abdominal discomfort
124467318 12446731 Cancer pain
124467318 12446731 Constipation
124467318 12446731 Death
124467318 12446731 Disease progression
124467318 12446731 Fatigue
124467318 12446731 Hypersomnia
124467318 12446731 Hypoaesthesia
124467318 12446731 Pain in extremity
124467318 12446731 Paraesthesia
124467318 12446731 Renal cancer stage IV
124467318 12446731 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124467318 12446731 1 20160427 0
124467318 12446731 6 20151217 0
124467318 12446731 7 20141121 0
124467318 12446731 9 20151230 0